| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cc4274be0f870436689ca89b2c78642f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_184f450d82fc919d7db022d94ab41ecf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c43d3df20da48e2043414a0db45c0d18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_910c2c7cc0b1e2f251114eb1c74cdeff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a21b39906035690dc89b38e6d53f5bf9 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2840-20 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-20 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-79 |
| filingDate |
1999-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aee8150930301474b06cd699c7e7407b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9de1951d546d537f04f4dc3ce10de7d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ced08a55be8b21e8e47660615fa3619
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb1930e6385288a031a0ece6fbde337e |
| publicationDate |
2000-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0040737-A1 |
| titleOfInvention |
High efficiency mammalian gene expression vectors that contain exogenous promoter and entire 5' untranslated region in the upstream from start codon for inherent gene as transcription regulatory site |
| abstract |
The present invention relates to the highly efficient eukaryotic expression vectors which have regulatory sequences derived from human cytomegalovirus immediate early gene or human EF1α gene, thereof transcriptional regulatory regions contain exogenous promoter and entire 5' untranslated region correspond to the condition of inherent gene expression. Therefore, the eukaryotic expression vectors provided in accordance with the present invention can drive high levels of gene expression in human and animal cells and have utilities as gene therapy agent. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7429480-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11510999-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8105575-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9963511-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10882910-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009093880-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02053191-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10639351-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7175840-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0151626-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0151626-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7279568-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015060650-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11219667-B2 |
| priorityDate |
1998-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |